Recombinant AAV particles were generated as described before (41). Briefly, vectors were propagated in HEK293T cells using the pDP6 helper plasmid (avoiding adenoviral contamination). Viral particles were purified by iodixanol step gradient centrifugation followed by heparin affinity chromatography. Fast protein liquid chromatography–purified/concentrated vectors were desalted by dialysis against phosphate-buffered saline (PBS). Viral titer was adjusted by serial dilution on primary hippocampal neurons by monitoring GFP expression levels (always expressed in a second cassette of the construct, driven by the human synapsin-1 promoter).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.